Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting ADMA With Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

NCT03471117 is registered in ClinicalTrials.gov with The University of Texas at Arlington as lead sponsor.

NCT NCT03471117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03471117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting ADMA With Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
Lead sponsor
The University of Texas at Arlington
Phase
Phase 4
Overall status
Terminated
Start date
April 1, 2018
Completion date
January 14, 2020
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases